Dual affinity RE-targeting molecules for HIV-1 suppression

Ended Definitive Contract Awarded Last action

Contract number
HHSN272201500032C
Awardee
Awarding agency
Obligated
$24,570,214

Award facts

Opportunity
Contract value 100% obligated
$24,570,214.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 3 offers Negotiated Proposal / Quote
Pricing
Cost Plus Fixed Fee
Place of performance
Rockville, MD 20850, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00015 · To administrate DE-obligate unexpended and expiring fiscal year 2021 funding in accordance with 31 -$549,735
Other Administrative Action P00014 $0
Change Order P00013 $0
Other Administrative Action P00012 $0
Other Administrative Action P00011 $0
Other Administrative Action P00010 $0
Other Administrative Action P00009 $0
Change Order P00008 $6,287,950
Other Administrative Action P00007 $0
Funding Only Action P00006 -$671,380
Other Administrative Action P00005 $0
Other Administrative Action P00004 $0
Change Order 3 · The objectives of this contract are to perform product development and advance therapeutic products, dual affinity RE-targeting (DART)-1 and DART-2, into… $1,263,565
Exercise an Option 2 $10,790,360
Other Administrative Action 1 $0
Original award $7,449,454
Show all 16

About this award

Written by GovTribe AI ·

The National Institute of Allergy and Infectious Diseases awarded a definitive contract to Macrogenics, Inc. for dual affinity re-targeting molecules for HIV-1 suppression on September 14, 2015, with a ceiling value of $24.57 million under cost-plus-fixed-fee pricing and no set-aside.

Place of performance is Rockville, MD. The award was issued to de-obligate unexpended and expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a) in preparation for the September 30, 2026 close of the period of availability for those funds.

In FY2024, the most recent reported fiscal year, the contract engaged 3.7 FTEs across 7,700 contractor hours at a derived government-paid rate of $244.00 per hour, with all work self-performed by the prime. FY2023 showed substantially higher invoicing ($22.4 million on 7.9 FTEs and 16,474 contractor hours) with a derived rate of $1,360.89 per hour, reflecting a spike in that year's activity. FY2021 and FY2022 invoiced at approximately $244 per hour; the contract's invoiced rate has remained roughly flat across reported years excluding the FY2023 outlier.

Quick answers

Who was awarded contract HHSN272201500032C?

HHSN272201500032C was awarded to Macrogenics, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 14, 2015.

How much is contract HHSN272201500032C worth?

The government has obligated $24,570,214 on HHSN272201500032C.

Was contract HHSN272201500032C competed?

The extent of competition for HHSN272201500032C was full and open competition. The government received 3 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login